Search

Your search keyword '"oncolytic"' showing total 540 results

Search Constraints

Start Over You searched for: Descriptor "oncolytic" Remove constraint Descriptor: "oncolytic"
540 results on '"oncolytic"'

Search Results

1. An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy.

2. An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy

3. Treatment of malignant melanoma with coxsackievirus A21 (V937): An emerging oncolytic virotherapy.

4. The in vitro Potential Oncolytic Effect of Lentogenic and Velogenic Newcastle Disease Viruses on MCF-7 and Caco-2 Cell Lines Compared to Chemotherapies

5. Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications.

6. Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth.

7. The in vitro Potential Oncolytic Effect of Lentogenic and Velogenic Newcastle Disease Viruses on MCF-7 and Caco-2 Cell Lines Compared to Chemotherapies.

8. Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses

9. Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12

10. Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors

11. Exploring the relationship between cancer metabolism and oncolytic adenoviruses

12. Assessing the mechanistic synergy between cancer virotherapy and external beam radiation

13. Attenuated Dengue virus PV001-DV induces oncolytic tumor cell death and potent immune responses.

14. Infectious Recombinant Senecavirus A Expressing p16 INK4A Protein.

15. Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells.

16. Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth

17. Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications

18. Multiple potential recombination events among Newcastle disease virus genomes in China between 1946 and 2020

20. Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10

21. Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus

22. Cancer immunomodulation using bispecific aptamers

23. NEBL and AKT1 maybe new targets to eliminate the colorectal cancer cells resistance to oncolytic effect of vesicular stomatitis virus M-protein

24. The Effects of Oncolytic Pseudorabies Virus Vaccine Strain Inhibited the Growth of Colorectal Cancer HCT-8 Cells In Vitro and In Vivo.

25. Biophysical Characterization of LTX-315 Anticancer Peptide Interactions with Model Membrane Platforms: Effect of Membrane Surface Charge.

26. Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation

27. The progress and research trends in oncolytic virotherapy: The bibliometric analysis from 2000 to 2019

28. Oncolytic Rodent Protoparvoviruses Evade a TLR- and RLR-Independent Antiviral Response in Transformed Cells

29. Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy

30. Adaptations and Advancement of Biologic Immunotherapy in the Management of Immunologically Cold Solid Malignancies

31. Oncolytic viruses for cancer immunotherapy

32. Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA

33. Oncolytic viruses and pancreatic cancer

34. Investigating the effect of reduced temperatures on the efficacy of rhabdovirus-based viral vector platforms.

35. Antitumor immunity enhancement through Newcastle viral oncolysate in mice model: A promising method to treat tumors.

36. Bioprocessing of oncolytic group B adenovirus for scalable production

37. The Effects of Oncolytic Pseudorabies Virus Vaccine Strain Inhibited the Growth of Colorectal Cancer HCT-8 Cells In Vitro and In Vivo

38. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model.

39. Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11.

40. Development of sindbis virus as an oncolytic agent

41. Liver specific microRNA control of adenovirus serotype five

42. Improving intraperitoneal adenovirus virotherapy for ovarian cancer

43. A Retrospective Chart Review Study of Real-World Use of Talimogene Laherparepvec in Unresectable Stage IIIB–IVM1a Melanoma in Four European Countries.

44. Oncolytic viruses for cancer immunotherapy.

45. Administration sequence for multi-agent oncolytic regimens.

46. Epstein-Barr Virus Lytic Cycle Reactivation

47. Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model

48. OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution

49. Zika Virus as Oncolytic Therapy for Brain Cancer: Myth or Reality?

50. Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12.

Catalog

Books, media, physical & digital resources